For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Health Care & Hospital Law

Jan. 2, 2025

Novartis sued in LA over drug's link to autism 

Novartis is sued for promoting terbutaline for preterm labor, despite known brain development risks. Singleton Schreiber filed the lawsuit for Tara Tindle, claiming her child has autism, linked to terbutaline use.

Novartis Pharmaceutical Corp. is accused in a lawsuit of promoting an asthma drug to treat preterm labor in pregnant women despite knowing that it posed significant risks to the development of their babies' brains.

Christopher R. Rodriguez of Singleton Schreiber LLP filed the lawsuit Monday in Los Angeles County Superior Court, claiming the plaintiff, Tara Tindle, was prescribed terbutaline for approximately 16-20 weeks while she was pregnant. Her child was born in 2003 and su...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Sign up for Daily Journal emails



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.